يعرض 1 - 20 نتائج من 475 نتيجة بحث عن '"Dolor torácico"', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 1
    Dissertation/ Thesis

    المساهمون: University/Department: Universitat de Lleida. Departament de Medicina i Cirurgia

    Thesis Advisors: Ortega Bravo, Marta, Yuguero Torres, Oriol, Trujillano Cabello, Javier

    المصدر: TDX (Tesis Doctorals en Xarxa)

    Time: 616.1

    وصف الملف: application/pdf

  2. 2
    Dissertation/ Thesis

    المؤلفون: Riesgo García, Alba

    المساهمون: University/Department: Universitat de Barcelona. Departament de Medicina

    Thesis Advisors: Miró i Andreu, Òscar, Bragulat Baur, Ernesto

    المصدر: TDX (Tesis Doctorals en Xarxa)

    Time: 616.1

    وصف الملف: application/pdf

  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Dissertation/ Thesis

    المساهمون: University/Department: Universitat Autònoma de Barcelona. Departament de Medicina

    Thesis Advisors: Candell Riera, Jaume

    المصدر: TDX (Tesis Doctorals en Xarxa)

    مصطلحات موضوعية: Gammagrafía, Dolor torácico, Infarto, Ciències de la Salut

    Time: 616.1

    وصف الملف: application/pdf

  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
  14. 14
    Academic Journal

    المصدر: RFS Revista Facultad de Salud; Vol. 15 (2023): MEMORIAS PRIMER CONGRESO SURCOLOMBIANO DE MEDICINA INTERNA; 38-57 ; 2389-9298 ; 2145-1362

    وصف الملف: application/pdf

    Relation: http://journalusco.edu.co/index.php/rfs/article/view/3896/4757; Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. European Society of Cardiology: cardiovascular disease; statistics 2021. Eur Heart J 2022;43:716–799. https://doi.org/10.1093/eurheartj/ehab892; Kuznetsova T. Sex differences in epidemiology of cardiac and vascular disease. Adv Exp Med Biol 2018; 1065:61–70.; Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics-2021 update; a report from the American Heart Association. Circulation 2021;143:e254–e743. https://doi.org/10.1161/cir.0000000000000950; Sugiyama T, Hasegawa K, Kobayashi Y, Takahashi O, Fukui T, Tsugawa Y. Differential time trends of outcomes and costs of care; for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001–2011. J Am; Heart Assoc 2015;4:e001445. https://doi.org/10.1161/jaha.114.001445; Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P, et al. Acute myocardial infarction: changes in patient characteristics; management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French registry of acute ST-elevation or; non-ST-elevation myocardial infarction) 1995 to 2015. Circulation 2017;136:1908–1919.; García-García C, Oliveras T, Serra J, Vila J, Rueda F, Cediel G, et al. Trends in short- and long-term ST-segment-elevation; myocardial infarction prognosis over 3 decades: a Mediterranean population-based ST-segment-elevation myocardial infarction; registry. J Am Heart Assoc 2020;9:e017159. https://doi.org/10.1161/jaha.120.017159; Gale CP, Allan V, Cattle BA, Hall AS, West RM, Timmis A, et al. Trends in hospital treatments, including revascularisation, following; acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular; Outcomes Research (NICOR). Heart 2014;100:582–589. https://doi.org/10.1136/heartjnl-2013-304517; Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction; Eur Heart J 2019;40:237–269. https://doi.org/10.1093/eurheartj/ehy462; Robert A Byrne, Xavier Rossello, J J Coughlan, Emanuele Barbato, Colin Berry, Alaide Chieffo, Marc J Claeys, Gheorghe-Andrei; Dan, Marc R Dweck, Mary Galbraith, Martine Gilard, Lynne Hinterbuchner, Ewa A Jankowska, Peter Jüni, Takeshi Kimura, Vijay; Kunadian, Margret Leosdottir, Roberto Lorusso, Roberto F E Pedretti, Angelos G Rigopoulos, Maria Rubini Gimenez, Holger Thiele; Pascal Vranckx, Sven Wassmann, Nanette Kass Wenger, Borja Ibanez, ESC Scientific Document Group , 2023 ESC Guidelines; for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes; of the European Society of Cardiology (ESC), European Heart Journal, Volume 44, Issue 38, 7 October 2023, Pages 3720–3826; Anderson HVS, Masri SC, Abdallah MS, Chang AM, Cohen MG, Elgendy IY, et al. 2022 ACC/AHA key data elements and definitions; for chest pain and acute myocardial infarction: a report of the American Heart Association/American College of Cardiology Joint; Committee on clinical data standards. J Am Coll Cardiol 2022;80:1660–1700. https://doi.org/10.1016/j.jacc.2022.05.012; Chiaramonte GR, Friend R. Medical students’ and residents’ gender bias in the diagnosis, treatment, and interpretation of coronary; heart disease symptoms. Health Psychol 2006;25:255–266. https://doi.org/10.1037/0278-6133.25.3.255; Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute; coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute; R.F.S Revista Facultad de Salud Síndrome coronario agudo: más allá de la troponina.; Número suplementar, diciembre 2023: 37-57; R.F.S. Revista Facultad de Salud 52; coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).; Eur Heart J 2021;42:1289–1367. https://doi.org/10.1093/eurheartj/ehaa575; Gimenez MR, Reiter M, Twerenbold R, Reichlin T, Wildi K, Haaf P, et al. Sex-specific chest pain characteristics in the early diagnosis; of acute myocardial infarction. JAMA Intern Med 2014;174:241–249. https://doi.org/10.1001/jamainternmed.2013.12199; Nestelberger T, Cullen L, Lindahl B, Reichlin T, Greenslade JH, Giannitsis E, et al. Diagnosis of acute myocardial infarction in the; presence of left bundle branch block. Heart 2019;105:1559–1567. https://doi.org/10.1136/heartjnl-2018-314673; Meyer MR, Radovanovic D, Pedrazzini G, Rickli H, Roffi M, Rosemann T, et al. Differences in presentation and clinical outcomes; between left or right bundle branch block and ST segment elevation in patients with acute myocardial infarction. Eur Heart J Acute; Cardiovasc Care 2020;9:848–856. https://doi.org/10.1177/2048872620905101; Lai YC, Chen YH, Wu KH, Chen YC. Validation of the diagnosis and triage algorithm for acute myocardial infarction in the setting; of left bundle branch block. Am J Emerg Med 2020;38:2614–2619. https://doi.org/10.1016/j.ajem.2020.03.02; Neumann JT, Sorensen NA, Rubsamen N, Ojeda F, Schäfer S, Keller T, et al. Right bundle branch block in patients with suspected; myocardial infarction. Eur Heart J Acute Cardiovasc Care 2019;8:161–166. https://doi.org/10.1177/2048872618809700; Rubini Gimenez M, Twerenbold R, Boeddinghaus J, Nestelberger T, Puelacher C, Hillinger P, et al. Clinical effect of sex-specific; cutoff values of high-sensitivity cardiac troponin T in suspected myocardial infarction. JAMA Cardiol 2016;1:912–920.; Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Chapman AR, et al. High-sensitivity troponin in the evaluation of patients; with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet 2018;392:919–928.; Ljung L, Lindahl B, Eggers KM, Frick M, Linder R, Löfmark HB, et al. A rule-out strategy based on high-sensitivity troponin and; HEART score reduces hospital admissions. Ann Emerg Med 2019;73:491–499.; Boeddinghaus J, Lopez-Ayala P, Nestelberger T, Koechlin L, Münch T, Miro O, et al. Prospective validation of the ESC 0/1halgorithm using high-sensitivity cardiac troponin I. Am J Cardiol 2021;158:152–153. https://doi.org/10.1016/j.amjcard.2021.08.007; Boeddinghaus J, Nestelberger T, Lopez-Ayala P, Koechlin L, Buechi M, Miro O, et al. Diagnostic performance of the European; Society of Cardiology 0/1-h algorithms in late presenters. J Am Coll Cardiol 2021;77:1264–1267.; Badertscher P, Boeddinghaus J, Twerenbold R, Nestelberger T, Wildi K, Wussler D, et al. Direct comparison of the 0/1h and 0/3h; algorithms for early rule-out of acute myocardial infarction. Circulation 2018;137:2536–2538.; Twerenbold R, Neumann JT, Sorensen NA, Ojeda F, Karakas M, Boeddinghaus J, et al. Prospective validation of the 0/1-h; algorithm for early diagnosis of myocardial infarction. J Am Coll Cardiol 2018;72:620–632.; Chew DP, Lambrakis K, Blyth A, Seshadri A, Edmonds MJR, Briffa T, et al. A randomized trial of a 1-hour troponin T protocol in; suspected acute coronary syndromes: the rapid assessment of possible acute coronary syndrome in the emergency department; with high-sensitivity troponin T study (RAPID-TnT). Circulation 2019;140:1543–1556.; Stoyanov KM, Hund H, Biener M, Gandowitz J, Riedle C, Löhr J, et al. RAPID-CPU: a prospective study on implementation of the; ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction. Eur Heart J Acute Cardiovasc Care; 2019;9:39–51.; Twerenbold R, Costabel JP, Nestelberger T, Campos R, Wussler D, Arbucci R, et al. Outcome of applying the ESC 0/1-hour; algorithm in patients with suspected myocardial infarction. J Am Coll Cardiol 2019;74:483–494.; Nestelberger T, Boeddinghaus J, Wussler D, Twerenbold R, Badertscher P, Wildi K, et al. Predicting major adverse events in; patients with acute myocardial infarction. J Am Coll Cardiol 2019;74:842–854. https://doi.org/10.1016/j.jacc.2019.06.025; Nestelberger T, Wildi K, Boeddinghaus J, Twerenbold R, Reichlin T, Giménez MR, et al. Characterization of the observe zone of; the ESC 2015 high-sensitivity cardiac troponin 0h/1h-algorithm for the early diagnosis of acute myocardial infarction. Int J Cardiol; 2016;207:238–245. https://doi.org/10.1016/j.ijcard.2016.01.112; Dedic A,Lubbers MM,chaap j,Lammers j,Lamparas EJ,Rendiendo bj, et al. Angiografía coronaria por TC por sospecha de SCA en; la era de las troponinas de alta sensibilidad: estudio multicéntrico aleatorizado.J. Am Coll Cardiol 2016;67:dieciséis–26.; R.F.S. Revista Facultad de Salud 53; Gris AJ,Fondo del tejado C,Herrero JE,Goodacre S,Oatey k,O'Brien R, et al. Angiografía coronaria por tomografía computarizada; temprana en pacientes con sospecha de síndrome coronario agudo: ensayo controlado aleatorio.BMJ 2021;374:n2106.; Kofoed KF, Engstrom T, Sigvardsen PE, Linde JJ, Torp-Pedersen C, de Knegt M, et al. Prognostic value of coronary CT; angiography in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2021;77:1044–1052.; Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a; quantitative review of 23 randomised trials. Lancet 2003;361:13–20. https://doi.org/10.1016/s0140-6736(03)12113-7; Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et al. Coronary intervention for persistent occlusion; after myocardial infarction. N Engl J Med 2006;355:2395–2407. https://doi.org/10.1056/NEJMoa066139; Menon V, Pearte CA, Buller CE, Steg PhG, Forman SA, White HD, et al. Lack of benefit from percutaneous intervention of; persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded; Artery Trial. Eur Heart J 2009;30:183–191. https://doi.org/10.1093/eurheartj/ehn486; Ioannidis JPA, Katritsis DG. Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients.; Am Heart J 2007;154:1065–1071. https://doi.org/10.1016/j.ahj.2007.07.049; Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al. Routine early angioplasty after fibrinolysis for acute; myocardial infarction. N Engl J Med 2009;360:2705–2718. https://doi.org/10.1056/NEJMoa0808276; Fazel R, Joseph TI, Sankardas MA, Pinto DS, Yeh RW, Kumbhani DJ, et al. Comparison of reperfusion strategies for ST-segmentelevation myocardial infarction: a multivariate network meta-analysis. J Am Heart Assoc 2020;9:e015186.; Abdel-Qadir H, Yan AT, Tan M, Borgia F, Piscione F, Di Mario C, et al. Consistency of benefit from an early invasive strategy after; fibrinolysis: a patient-level meta-analysis. Heart 2015;101:1554–1561. https://doi.org/10.1136/heartjnl-2015-307815; Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute; coronary syndromes. N Engl J Med 2009;361:1045–1057. https://doi.org/10.1056/NEJMoa0904327; Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with; acute coronary syndromes. N Engl J Med 2007;357:2001–2015. https://doi.org/10.1056/NEJMoa0706482; Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, et al. Bleeding and stent thrombosis on P2Y12-inhibitors; collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J; 2015;36:1762–1771. https://doi.org/10.1093/eurheartj/ehv104; Gimbel M, Qaderdan K, Willemsen L, Hermanides R, Bergmeijer T, de Vrey E, et al. Clopidogrel versus ticagrelor or prasugrel in; patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, noninferiority trial. Lancet 2020;395:1374–1381. https://doi.org/10.1016/s0140-6736(20)30325-1; Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, et al. Ticagrelor or prasugrel in patients with acute; coronary syndromes. N Engl J Med 2019;381:1524–1534. https://doi.org/10.1056/NEJMoa1908973; Montalescot G, van’t Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, et al. Prehospital ticagrelor in ST-segment elevation; myocardial infarction. N Engl J Med 2014;371:1016–1027. https://doi.org/10.1056/NEJMoa1407024; Koul S, Smith JG, Götberg M, Omerovic E, Alfredsson J, Venetsanos D, et al. No benefit of ticagrelor pretreatment compared with; treatment during percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction undergoing; primary percutaneous coronary intervention. Circ Cardiovasc Interv 2018;11:e005528.; Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay J-F, et al. Pretreatment with prasugrel in non-ST-segment; elevation acute coronary syndromes. N Engl J Med 2013;369:999–1010. https://doi.org/10.1056/NEJMoa1308075; Montalescot G, Zeymer U, Silvain J, Boulanger B, Cohen M, Goldstein P, et al. Intravenous enoxaparin or unfractionated heparin; in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label; ATOLL trial. Lancet 2011;378:693–703. https://doi.org/10.1016/s0140-6736(11)60876-3; Li Y, Liang Z, Qin L, Wang M, Wang X, Zhang H, et al. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients; with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial. Lancet; 2022;400:1847–1857. https://doi.org/10.1016/s0140-6736(22)01999-7; Silvain J, Beygui F, Barthélémy O, Pollack C, Cohen M, Zeymer U, et al. Efficacy and safety of enoxaparin versus unfractionated; heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ 2012;344:e553.; R.F.S. Revista Facultad de Salud 54; The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators. Comparison of fondaparinux and; enoxaparin in acute coronary syndromes. N Engl J Med 2006;354:1464–1476. https://doi.org/10.1056/NEJMoa055443; Sabatine MS, Bergmark BA, Murphy SA, O’Gara PT, Smith PK, Serruys PW, et al. Percutaneous coronary intervention with drugeluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.; Lancet 2021;398:2247–2257. https://doi.org/10.1016/s0140-6736(21)02334-5; Head SJ, Milojevic M, Daemen J, Ahn J-M, Boersma E, Christiansen EH, et al. Mortality after coronary artery bypass grafting; versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.; Lancet 2018;391:939–948. https://doi.org/10.1016/s0140-6736(18)30423-9; Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction; complicated by cardiogenic shock. N Engl J Med 1999;341:625–634. https://doi.org/10.1056/nejm199908263410901; Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI strategies in patients with acute myocardial infarction; and cardiogenic shock. N Engl J Med 2017;377:2419–2432. https://doi.org/10.1056/NEJMoa1710261; Bainey KR, Engstrøm T, Smits PC, Gershlick AH, James SK, Storey RF, et al. Complete vs culprit-lesion-only revascularization for; ST-segment elevation myocardial infarction: a systematic review and meta-analysis. JAMA Cardiol 2020;5:881–888.; Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, et al. Complete revascularization with multivessel PCI for; myocardial infarction. N Engl J Med 2019;381:1411–1421. https://doi.org/10.1056/NEJMoa1907775; Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease; prevention in clinical practice. Eur Heart J 2021;42:3227–3337. https://doi.org/10.1093/eurheartj/ehab484; Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic; cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European; Atherosclerosis Society Consensus Panel. Eur Heart J 2017;38:2459–2472. https://doi.org/10.1093/eurheartj/ehx144; Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of; dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111–188.; Navarese EP, Kowalewski M, Andreotti F, van Wely M, Camaro C, Kolodziejczak M, et al. Meta-analysis of time-related benefits; of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol; 2014;113:1753–1764. https://doi.org/10.1016/j.amjcard.2014.02.034; Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute; coronary syndromes. N Engl J Med 2015;372:2387–2397. https://doi.org/10.1056/NEJMoa1410489; Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, et al. Alirocumab and cardiovascular outcomes after acute; coronary syndrome. N Engl J Med 2018;379:2097–2107. https://doi.org/10.1056/NEJMoa180117; Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for; hypertriglyceridemia. N Engl J Med 2019;380:11–22. https://doi.org/10.1056/NEJMoa1812792; Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, et al. Rationale and design of the; pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). Eur; Heart J Cardiovasc Pharmacother 2021;8:291–301. https://doi.org/10.1093/ehjcvp/pvab060; Munkhaugen J, Ruddox V, Halvorsen S, Dammen T, Fagerland MW, Hernæs KH, et al. BEtablocker Treatment After acute; Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): rationale and design of; a prospective, randomized, open, blinded end point study. Am Heart J 2019;208:37–46. https://doi.org/10.1016/j.ahj.2018.10.005; Kristensen AMD, Bovin A, Zwisler AD, Cerquira C, Torp-Pedersen C, Bøtker HE, et al. Design and rationale of the Danish trial of; beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.; Trials 2020;21:415. https://doi.org/10.1186/s13063-020-4214-6; Watanabe H, Ozasa N, Morimoto T, Shiomi H, Bingyuan B, Suwa S, et al. Long-term use of carvedilol in patients with ST-segment; elevation myocardial infarction treated with primary percutaneous coronary intervention. PLoS One 2018;13:e0199347.; Zeitouni M, Kerneis M, Lattuca B, Guedeney P, Cayla G, Collet JP, et al. Do patients need lifelong β-blockers after an; uncomplicated myocardial infarction? Am J Cardiovasc Drugs 2019;19:431–438. https://doi.org/10.1007/s40256-019-00338-4; Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients; with left ventricular dysfunction after myocardial infarction–results of the survival and ventricular enlargement trial. N Engl J Med; 1992;327:669–677. https://doi.org/10.1056/nejm199209033271001; R.F.S. Revista Facultad de Salud 55; The AIRE Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical; evidence of heart failure. Lancet 1993;342:821–828. https://doi.org/10.1016/0140-6736(93)92693-N; Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, et al. Valsartan, captopril, or both in myocardial; infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003;349:1893–1906.; Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, et al. Angiotensin receptor-neprilysin inhibition in acute; myocardial infarction. N Engl J Med 2021;385:1845–1855. https://doi.org/10.1056/NEJMoa2104508; Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with; left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309–1321. https://doi.org/10.1056/NEJMoa030207; Montalescot G, Pitt B, Lopez de Sa E, Hamm CW, Flather M, Verheugt F, et al. Early eplerenone treatment in patients with acute; ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study. Eur Heart J 2014;35:2295–; Cowie MR, Fisher M. SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control. Nat Rev Cardiol; 2020;17:761–772. https://doi.org/10.1038/s41569-020-0406-8; Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in; type 2 diabetes. N Engl J Med 2017;377:644–657. https://doi.org/10.1056/NEJMoa1611925; Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes.; N Engl J Med 2019;380:347–357. https://doi.org/10.1056/NEJMoa1812389; Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, et al. Empagliflozin in heart failure with a preserved ejection; fraction. N Engl J Med 2021;385:1451–1461. https://doi.org/10.1056/NEJMoa2107038; Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in heart failure with mildly; reduced or preserved ejection fraction. N Engl J Med 2022;387:1089–1098. https://doi.org/10.1056/NEJMoa2206286; Harrington J, Udell JA, Jones WS, Anker SD, Bhatt DL, Petrie MC, et al. Empagliflozin in patients post myocardial infarction; rationale and design of the EMPACT-MI trial. Am Heart J 2022;253:86–98. https://doi.org/10.1016/j.ahj.2022.05.010; von Lewinski D, Kolesnik E, Tripolt NJ, Pferschy PN, Benedikt M, Wallner M, et al. Empagliflozin in acute myocardial infarction: the; EMMY trial. Eur Heart J 2022;43:4421–4432. https://doi.org/10.1093/eurheartj/ehac494; Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al. Cardiovascular, mortality, and kidney outcomes with; GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.; Lancet Diabetes Endocrinol 2019;7:776–785. https://doi.org/10.1016/s2213-8587(19)30249-9; Lai KC, Lam SK, Chu KM, Wong BCY, Hui WM, Hu WHC, et al. Lansoprazole for the prevention of recurrences of ulcer; complications from long-term low-dose aspirin use. N Engl J Med 2002;346:2033–2038. https://doi.org/10.1056/NEJMoa012877; Casado Arroyo R, Polo-Tomas M, Roncalés MP, Scheiman J, Lanas A. Lower GI bleeding is more common than upper among; patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy. Heart 2012;98:718–; Small DS, Farid NA, Payne CD, Weerakkody GJ, Li YG, Brandt JT, et al. Effects of the proton pump inhibitor lansoprazole on the; pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J Clin Pharmacol 2008;48:475–484.; Patterson t,Perkins Dios,Hassan Y,Moschonas k,Gris h,Curzen norte, et al. Tendencias temporales en la identificación, el; tratamiento y los resultados clínicos después de un paro cardíaco extrahospitalario: conocimientos de la base de datos del proyecto; nacional de auditoría de isquemia miocárdica.Interv Circ Cardiovascular 2018;11:e005346.; krupa j,Nudo j,Ulmán j,Bednar F,Dohnálova A,Motovska z.Características y determinantes de la supervivencia en pacientes tras; un paro cardíaco extrahospitalario en la era de los centros de intervención coronaria 24 horas al día, 7 días a la semana.Circo; corazón-pulmón 2017;26:799–807. https://doi.org/10.1016/j.hlc.2016.11.012; Dumas F, Cariou A, Manzo-Silberman S, Grimaldi D, Vivien B, Rosencher J, et al. Immediate percutaneous coronary intervention; is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital; Cardiac ArresT) registry. Circ Cardiovasc Interv 2010;3:200–207. https://doi.org/10.1161/circinterventions.109.913665; Rab T, Kern KB, Tamis-Holland JE, Henry TD, McDaniel M, Dickert NW, et al. Cardiac arrest: a treatment algorithm for emergent; invasive cardiac procedures in the resuscitated comatose patient. J Am Coll Cardiol 2015;66:62–73.; R.F.S. Revista Facultad de Salud 56; Gorjup V, Radsel P, Kocjancic ST, Erzen D, Noc M. Acute ST-elevation myocardial infarction after successful cardiopulmonary; resuscitation. Resuscitation 2007;72:379–385. https://doi.org/10.1016/j.resuscitation.2006.07.013; Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen MM, et al. Coronary angiography after; cardiac arrest without ST segment elevation: one-year outcomes of the COACT randomized clinical trial. JAMA Cardiol; 2020;5:1358–1365. https://doi.org/10.1001/jamacardio.2020.3670; Desch S, Freund A, Akin I, Behnes M, Preusch MR, Zelniker TA, et al. Angiography after out-of-hospital cardiac arrest without STsegment elevation. N Engl J Med 2021;385:2544–2553. https://doi.org/10.1056/NEJMoa2101909; Kern KB, Radsel P, Jentzer JC, Seder DB, Lee KS, Lotun K, et al. Randomized pilot clinical trial of early coronary angiography; versus no early coronary angiography after cardiac arrest without ST-segment elevation: the PEARL study. Circulation; 2020;142:2002–2012. https://doi.org/10.1161/circulationaha.120.049569; Hauw-Berlemont C, Lamhaut L, Diehl JL, Andreotti C, Varenne O, Leroux P, et al. Emergency vs delayed coronary angiogram in; survivors of out-of-hospital cardiac arrest: results of the randomized, multicentric EMERGE trial. JAMA Cardiol 2022;7:700–707.; Hassager C, Schmidt H, Møller JE, Grand J, Mølstrøm S, Beske RP, et al. Duration of device-based fever prevention after cardiac; arrest. N Engl J Med 2023;388:888–897. https://doi.org/10.1056/NEJMoa2212528; White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, et al. Comparison of percutaneous coronary intervention; and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We; Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation 2005;112:1992–2001.; Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, et al. Early revascularization and long-term survival in; cardiogenic shock complicating acute myocardial infarction. JAMA 2006;295:2511–2515. https://doi.org/10.1001/jama.295.21.2511; Liakopoulos OJ, Schlachtenberger G, Wendt D, Choi Y-H, Slottosch I, Welp H, et al. Early clinical outcomes of surgical myocardial; revascularization for acute coronary syndromes complicated by cardiogenic shock: a report from the north-Rhine-Westphalia; surgical myocardial infarction registry. J Am Heart Assoc 2019;8:e012049. https://doi.org/10.1161/jaha.119.012049; Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich H-G, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction; with cardiogenic shock. N Engl J Med 2012;367:1287–1296. https://doi.org/10.1056/NEJMoa1208410; Schrage B, Ibrahim K, Loehn T, Werner N, Sinning J-M, Pappalardo F, et al. Impella support for acute myocardial infarction; complicated by cardiogenic shock. Circulation 2019;139:1249–1258. https://doi.org/10.1161/circulationaha.118.036614; Miller PE, Bromfield SG, Ma Q, Crawford G, Whitney J, DeVries A, et al. Clinical outcomes and cost associated with an intravascular; microaxial left ventricular assist device vs intra-aortic balloon pump in patients presenting with acute myocardial infarction; complicated by cardiogenic shock. JAMA Intern Med 2022;182:926–933. https://doi.org/10.1001/jamainternmed.2022.2735; Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, et al. Extracorporeal membrane oxygenation in the therapy; of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation 2022;147:454–464.; Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence; clinical features and prognostic implications. Eur Heart J 2009;30:1038–1045. https://doi.org/10.1093/eurheartj/ehn579; Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and; management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).; The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC). Developed; with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373–498.; Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, et al. Dual antithrombotic therapy with dabigatran after PCI in atrial; fibrillation. N Engl J Med 2017;377:1513–1524. https://doi.org/10.1056/NEJMoa1708454; Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJGL, Herrman J-P, et al. Use of clopidogrel with or without aspirin in; patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised; controlled trial. Lancet 2013;381:1107–1115. https://doi.org/10.1016/s0140-6736(12)62177-1; Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, et al. Antithrombotic therapy after acute coronary syndrome or; PCI in atrial fibrillation. N Engl J Med 2019;380:1509–1524. https://doi.org/10.1056/NEJMoa1817083; R.F.S. Revista Facultad de Salud 57; Gargiulo G, Goette A, Tijssen J, Eckardt L, Lewalter T, Vranckx P, et al. Safety and efficacy outcomes of double vs. triple; antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and metaanalysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. Eur Heart J 2019;40:3757–3767.; Matsumura-Nakano Y, Shizuta S, Komasa A, Morimoto T, Masuda H, Shiomi H, et al. Open-label randomized trial comparing oral; anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease; beyond 1 year after coronary stent implantation. Circulation 2019;139:604–616. https://doi.org/10.1161/circulationaha.118.036768; Velders MA, Boden H, Hofma SH, Osanto S, van der Hoeven BL, Heestermans AACM, et al. Outcome after ST elevation; myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol 2013;112:1867–; Bharadwaj A, Potts J, Mohamed MO, Parwani P, Swamy P, Lopez-Mattei JC, et al. Acute myocardial infarction treatments and; outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. Eur Heart J 2020;41:2183–2193.; Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology; developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and; Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the Task Force on cardio-oncology of; the European Society of Cardiology (ESC). Eur Heart J 2022;43:4229–4361. https://doi.org/10.1093/eurheartj/ehac244; Potts JE, Iliescu CA, Lopez Mattei JC, Martinez SC, Holmvang L, Ludman P, et al. Percutaneous coronary intervention in cancer; patients: a report of the prevalence and outcomes in the United States. Eur Heart J 2019;40:1790–1800.; Pothineni NV, Shah NN, Rochlani Y, Saad M, Kovelamudi S, Marmagkiolis K, et al. Temporal trends and outcomes of acute; myocardial infarction in patients with cancer. Ann Transl Med 2017;5:482. https://doi.org/10.21037/atm.2017.11.29; Mohamed MO, Van Spall HGC, Kontopantelis E, Alkhouli M, Barac A, Elgendy IY, et al. Effect of primary percutaneous coronary; intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity; score matching analysis. Eur Heart J Acute Cardiovasc Care 2021;10:829–839. https://doi.org/10.1093/ehjacc/zuaa032; Guddati AK, Joy PS, Kumar G. Analysis of outcomes of percutaneous coronary intervention in metastatic cancer patients with acute; coronary syndrome over a 10-year period. J Cancer Res Clin Oncol 2016;142:471–479. https://doi.org/10.1007/s00432-015-2056-; Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P, et al. Evaluation and management of cancer patients; presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and; the ESC Council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases. Eur Heart J Acute; Cardiovasc Care 2021;10:947–959. https://doi.org/10.1093/ehjacc/zuab056; http://journalusco.edu.co/index.php/rfs/article/view/3896

  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal

    المصدر: Acta Médica del Centro; Vol. 17, No. 3 (2023): Julio-Septiembre ; 2709-7927

    وصف الملف: application/pdf

    Relation: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1828/1654; https://revactamedicacentro.sld.cu/index.php/amc/article/view/1828/1683; Gupta V, Prabhakar A, Yadav M, Khandelwal N. Computed tomography imaging-based normative orbital measurement in Indian population. Indian J Ophthalmol [Internet]. 2019 [citado 15/12/2022];67(5):659-663. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498909/. https://doi.org/10.4103/ijo.IJO_1187_18; Juntunen MAK, Sepponen P, Korhonen K, Pohjanen VM, Ketola J, Kotiaho A, et al. Interior photon counting computed tomography for quantification of coronary artery calcium: pre-clinical phantom study. Biomed Phys Eng Express [Internet]. 2020 [citado 15/12/2022];6:055011. Disponible en: https://iopscience.iop.org/article/10.1088/2057-1976/aba133/pdf. https://doi.org/10.1088/2057-1976/aba133; Gil E. Factores de riesgo vascular. En: de la Sierra Iserte A, Navarro Colás S, Bernhardt X, Mont Girbau L, Riambau Alonso V, Xaubet Mit A, et al. Farreras Rozman Medicina Interna. 18 ed. Barcelona: Elsevier; 2016. p. 478.; Martínez González MA, Calasanz MJ, Tortosa A. Comparaciones de K medias (Tres o más grupos): Comparaciones no paramétricas de k medias independientes: test de Kruskal–Wallis. En: Martínez González MA, Sánchez Villegas A, Faulín Fajardo FJ. Bioestadística amigable. 2a ed. España: Universidad de Navarra; 2006. p. 435.; Sánchez-Delgado JA, Sánchez-Lara NE. Factores modificables de riesgo coronario y riesgo cardiovascular global. Rev Finlay [Internet]. 2021 [citado 15/12/2022];11(2):152-159. Disponible en: https://revfinlay.sld.cu/index.php/finlay/article/view/946/1986; Michelli BJ, Bellandi S, Brachetta FG, Knott K, Ferreyra KJ, Alveza J. Utilidad del score de calcio ecocardiográfico como herramienta predictiva de enfermedad coronaria obstructiva. Rev Argent Cardiol [Internet]. 2019 [citado 15/12/2022];87(6):470-478. Disponible en: http://www.scielo.org.ar/pdf/rac/v87n6/1850-3748-rac-87-06-470.pdf. http://dx.doi.org/10.7775/rac.es.v87.i6.15780; Vinter N, Christesen AMS, Mortensen LS, Urbonaviciene G, Lindholt J, Johnsen SP, et al. Coronary artery calcium score and the long-term risk of atrial fibrillation in patients undergoing non-contrast cardiac computed tomography for suspected coronary artery disease: a Danish registry-based cohort study. Eur Heart J Cardiovasc Imaging [Internet]. 2018 [citado 15/12/2022];19(8):926-932. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28977363/. https://doi.org/10.1093/ehjci/jex201; Ceponiene I, Nakanishi R, Osawa K, Kanisawa M, Nezarat N, Rahmani S, et al. Coronary Artery Calcium Progression Is Associated With Coronary Plaque Volume Progression: Results From a Quantitative Semiautomated Coronary Artery Plaque Analysis. JACC Cardiovasc Imaging [Internet]. 2018 [citado 15/12/2022];11(12):1785-1794. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29055625/. https://doi.org/10.1016/j.jcmg.2017.07.023; Liu X, Xu C, Liu C, Su X. Clinical characteristics and long-term prognosis of spontaneous coronary artery dissection: A single-center Chinese experience. Pak J Med Sci [Internet]. 2019 [citado 15/12/2022];35(1):106-112. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408650/. https://doi.org/10.12669/pjms.35.1.321; Yagel O, Shadafny N, Eliaz R, Dagan G, Leibowitz D, Tahiroglu I, et al. Long-Term Prognosis in Young Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention. Vasc Health Risk Manag [Internet]. 2021 [citado 15/12/2022];17:153-159. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064716/pdf/vhrm-17-153.pdf. https://doi.org/10.2147/vhrm.s298436; Gohmann RF, Lauten P, Seitz P, Krieghoff C, Lücke C, Gottschling S, et al. Combined coronary CT-angiography and TAVI-planning: a contrast-neutral routine approach for ruling-out significant coronary artery disease. J Clin Med [Internet]. 2020 [citado 15/12/2022];9(6):1623. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356559/. https://doi.org/10.3390/jcm9061623; Feuchtner G, Beyer C, Barbieri F, Spitaler P, Dichtl W, Friedrich G, et al. The Atherosclerosis Profile by Coronary Computed Tomography Angiography (CTA) in Symptomatic Patients with Coronary Artery Calcium Score Zero. Diagnostics [Internet]. 2022 [citado 15/12/2022];12(9):2042. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498007/pdf/diagnostics-12-02042.pdf. https://doi.org/10.3390/diagnostics12092042; Mohammadzadeh A, Farzaneh M, Zahedmehr A, Kiani R, Shakiba M, Borhani A, et al. Coronary CT angiography and dual-energy computed tomography in ischemic heart disease suspected patients. Arch Iran Med [Internet]. 2019 [citado 15/12/2022];22(7):376-383. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31679380/; Sociedad Española de Imagen Cardiaca [Internet]. Madrid: SEIC; c2022 [citado 15/12/2022]. ¿Qué es y para qué sirve el calcio-score?; [aprox. 3 pantallas]. Disponible en: https://ecocardio.com/documentos/biblioteca-preguntas-basicas/preguntas-al-radiologo/960-que-es-para-que-sirve-calcio-score.html; Kik CC, Slooff WBM, Moayeri N, de Jong PA, Muijs SPJ, Öner FC. Diagnostic accuracy of computed tomography angiography (CTA) for diagnosing blunt cerebrovascular injury in trauma patients: a systematic review and meta-analysis. Eur Radiol [Internet]. 2022 [citado 15/12/2022];32(4):2727-2738. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921112/. https://doi.org/10.1007/s00330-021-08379-7; Qamar SR, Jalal S, Nicolaou S, Tsang M, Gilhofer T, Saw J. Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure. EuroIntervention [Internet]. 2019 [citado 15/12/2022];15(8):663-670. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31217149/. https://doi.org/10.4244/eij-d-18-01107; Arbas Redondo E, Tebar Marquez D, Poveda Pinedo ID, Dalmau Gonzalez-Gallarza R, Valbuena Lopez SC, Guzman Martinez G, et al. Diagnostic and prognostic value of coronary artery calcium score of zero: is it time for guidelines to change? Eur Heart J [Internet]. 2020 [citado 15/12/2022];41(Suppl 2):ehaa946.1383. Disponible en: https://academic.oup.com/eurheartj/article/41/Supplement_2/ehaa946.1383/6004594. https://doi.org/10.1093/ehjci/ehaa946.1383; Miedema MD, Dardari ZA, Nasir K, Blankstein R, Knickelbine T, Oberembt. Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults. JAMA Netw Open [Internet]. 2019 [citado 15/12/2022];2(7):e197440. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646982/. https://doi.org/10.1001/jamanetworkopen.2019.7440; https://revactamedicacentro.sld.cu/index.php/amc/article/view/1828

  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal